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SUMMARY 
Platelet monoamine Oxidase (MAO) activity was estimated in 30 depressed patients treated with 
Imipramine or EGT over a period of 5 weeks and pretreatment and post treatment values were compared. 
Imipramine and EGT caused significant reduction of platelet MAO, which after 7 days washout period 
comes to the pretreatment level while subjects clinical status l cmained unchanged. The percentage blockade 
in platelet MAO values by Imipramine and EGT was 51.40± 13.43 and 34.73+24.27 respectively. 
Tricyclic antidepressant drugs are 
laterally corsidered to act effectively in 
ihe treatment of depression by increasing 
the fuictional levels of biogenic amines 
at specific brain receptor sites. Recen-
tly various studies, considering in vitro 
and in vivo effect of tricyclic on mono-
amines have appeared in the literature 
(Edwards and Burns, 1974; Roth and 
Gillis, 1974 a; Sullivan, 1977). These 
studies have demonstrated that inhibition 
of monoamine oxidase (MAO) plays a 
role in the clinical action of tricyclic 
anti-depressants. 
Various hypotheses—neurochemical, 
neuroatiatomical, neuroendocrinal and 
psychological have been propounded to 
understand the mechanism of action of 
electroconvulsive therapy (ECT) (Otta^ 
son, 1980; Miller, 1976; Weaver et al., 
1976) but it is not possible to pin point 
a single mechanism of action. The pre-
sent work is an endevaour in this area. 
Indian literature is short of studies 
conducted in this specific area (Trivedi 
et al, 1988 b) and the ones reported are 
in Schizophrenics (Sen Gupta et al., 
1981; Gupta et al., 1985; Trivedi et al., 
1987, 1988 a): 
Aim : to study the effect of treat-
ment (Tmipramine and EGT) and clini-
cal response on monoamine oxidase acti-
vity in depressed patients. 
Material and Methods 
Thirty male depressed patients (accor-
ding to IGD-IX- 296) and fulfilling re-
search diagnostic criteria (Spitzer et al., 
1978) and meeting predefined selection 
criteia were selected. These patients 
were randomly assigned to imipramine 
(Group A) or EGT (Group B) treatment. 
Only those subjects were chosen for 
study who were between 17-60 yrs, had 
minimum of 17 score on Hamilton Psy-
chiatric Rating Scale for depression 
(HRSD) (Hamilton, 1960), had haemo-
globin not less than 10 gm%, had absence 
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of mijor physical illness, papilloedema, 
glaucoma or prostratic hypertrophy, had 
no imnxliate danger of suicide and 
had not received EGT in the past 3 
months. 
Procedure 
All the experimental group subjects 
were kept drug free for 7 days and score 
oil HRSD was assessed on the day of star-
ting treatment (day O). 
Group A : Tne patients received 
tablet imipramine on a fixed dosage of 
225 mg/day in divided dosage which was 
achieved within a week starting from 75 
mg/day followed by 150 ing/day for next 
3 days and 225 mg/day thereafter and 
continued till the end of 5 week study 
periods provided there were no serious 
side effects of imipramine which were 
assessed clinically. 
Group B : Patients were given 
direct EGT; first 3 oa alternate days 
starting from day one, and on every fourth 
day thereafter to a maximum of 10 at the 
end of 5 weeks treatment phase. 
In both the above groups (A & B) 
the treatment was stopped at any assess-
ment point at which clinical improvement 
occured i.e. HRSD score falls on or below 
5 point. Subsequent to the completion of 
treatment, all the patients (Group A and 
B) were kepi drug free of imipramine and 
EGT for seven days so as to abolish im-
mediate effect of EGT and imipramine on 
platelet MAO. 
Patients were assessed on Hamilton 
Psychiatric Rating Scale for Depression 
at the tim: of inclusion in the study, then 
at weekly interval and after 7 days of 
postreatiuerit was'iout period. Blood was 
CLMW.I at the bigining of study, then at 
the completion of the treatment and after 
7 day- of post treatment washout. 
Details regarding sample collection and 
estinvitto'i >f Platelet MAO activity is 
given elsewhere ;TrivedJ et al., 1988 b). 
Results 
The mean age of the group was 40.3 
years (range 24-57). In the Imipramine 
group (N=15) 2 patients had shown 
improvement after 3 weeks, 4 patients 
after 4 weeks and in 9 patients treatment 
was continued till 5 weeks. The mean 
duration of Imipramine treatment was 
4.47 weeks. In EGT treatment group 
iN=15) 3 patients had shown improve-
ment after 3 weeks, 5 patients after 4 
weeks and in 7 patients the treatment was 
continued till 5 weeks. The mean dura-
tion of EGT treatment was 4.27 weeks. 
Table 1. Comparison of Hamilton Psychia-
tric rating scale for deperession (HRS-D) 
total scores in prelreatment, post treatment and 
post-treatment after washout period in E.C. T. 
and imipramine treated group of patients. 
Pre- Post- Post 
treatment treatment treatment 
after was-
hout 
(N=15) (N=15) (N=15) 
(A) IB) (C) 
ECT trea'ad imp 
Mean 28.47 4.73 5.87 
s.d. 4.41 4.09 4.80 
Range 22-39 0-14 0-14 
(D) (E) (F) 
Drug Irtaied g:oup 
Mean 28.26 5.00 5.07 
S.D. 3.94 4.23 4.40 
Range 22-36 0-13 0-13 
Significant comparisons : 
AVs.B : t = 13.80 ;d.f. -14 ;p<0.001 
AVs.C :t-13.93;d.f.=.14;p<0.001 
DVs.F. : t = 18.46 ;d.f.-14 ;p<0.001 
DVs.E : t-15.07 ;d.f. =>14 ;p<0.001 IMIPRAMINE & EOT ON PLATELET MAO  141 
E. G. T. and Imipramine produced 
significant improvement in depression but 
there was no significant difference bet-
ween the treatment modalities. 
Table 2. Comparison of platelet MAO 
values in E. C. T. and Imipramine treated 
"roup of patients in prelratment, post treatment 
and post-treatment after washout period. 
Pre-treatment 
Mean 
s.d. 
Range 
Post treatment 
Mean 
s.d. 
Range 
Post treatment after 
washout period 
Mean 
i.d. 
Range 
E.C.T. 
Group 
(N=15) 
(A) 
42.52 
21.20 
1.13—91 
(C) 
29.03 
18.05 
treated 
.31 
4.16—68.56 
(E) 
42.97 
26.85 
12.91—104.37 
Imipramine 
treated Group 
(N=>15) 
(B) 
41.82 
21.68 
16.17—116.60 
(D) 
20.79 
15.45 
9.13—73.38 
(F) 
31.90 
20.67 
14.84—110.33 
* MAO values were represented in n/mol/min/mg/ 
protein), Significant comparisons : 
BVsD: t=9.60 ;d.f.-14 ; p<0.001 
DVsF :t=.9.30;d.f.= 14 ;p<0.001 
AVsC :t=2.96; d.f. = 14 ;p<0.05 
There was significant decrease in 
mean post-treated platelet MAO values 
when compared to prctreatment values 
both in Imipramine and EGT group. 
There was again a increase in platelet 
MAO values at post treatment washout 
period which was significant in imipra-
mine group and insignificant in ECT 
group. Thus, it is evident that Imipra-
mine and EGT had reduced platelet 
MAO values in depressed patierts which 
tended to return more or less to pretreat-
ment values. 
Discussion 
To study the effect of Imipramine 
and EGT on platelet monoamire oxi-
dase activity of depressed patients, the 
pre-treatment and post-treatment mono-
amine oxidase values were compared and 
a signficant decrease was observed in 
post treatment period. The percentage 
blockade (decrease) of platelet monoamine 
oxidase activity was studied comparing 
the post-treatment after 7 days washout 
period values with that of post-treatment 
values. The pre-treatment values were 
not considered because in that period 
although patients were drug free for 7 
days, the disease process i.e. depres-
sion was there, which could have caused 
a faulty interpretation as it has already 
been seen that platelet MAO is increased 
in depressed patients (Mann, 1979; 
Trivedi et al., 1988b). Whereas taking 
into account, the post-treatment (after 7 
days washout period) values, the effect 
of depression on platelet MAO values 
was eliminated. The mean percentage 
blockade of MAO activity by Imipramine 
and EGT was found to be 51.40± 13.43 
and 34.73±24.27 respectively. 
In vitro inhibition of the enzyme 
monoamine oxidase has also been reported 
in several animal studies (Roth and Gillis 
1974, a & b). Sulivan et al. (1977) 
reported 40% decrease in platelet MAO 
activity in 11 male paients of primary 
depression after 3 weeks of treatment 
with imipramine or amitryptyline. 
Edwards and Burns (1974) reported 
in vitro inlubition of platelet MAO acti-142  j. K. TRIVEDI it al. 
vity by amttryptyline. Roth and Gillis 
(1974 a) working on mitochondrial pre-
parations of rabbit lung and brain obser-
ved that Oxidase deamination of tyra-
mine, 5HT and bata-phenyle thylamine 
(PEA) was inhibited by imipramine. 
The same workers in another study (Roth 
and Gillis, 1974 b) determined the abi-
lity of several structurally related tricy-
clic antidepressant drugs to inhibit both 
the type A form of the MAO (5HT 
determination) and the type B form of 
the enzyme (PEA deamination). Howr 
ever, several reports challenge the pro-
posal that tricyclic antidepressants affect 
MAO activity (Revcley el al., 1979; 
Davidson etal., 1978; Gdler ct al., 1980). 
Reveley et al. (1979) did not find any 
significant inhibition of platelet MAO 
activity in depresses treated by ami-
tryptiline for 4 weeks. Thus, the pre-
sent observation of significant inhibition 
of MAO activity by imipramine supports 
other workers observation of inhibition 
of both types of mitrochondrial MAO and 
suggests that 'imipramint: inhibition' of 
the oxidative deamination of NE, 5HT, 
PEA and other biogenic amines may 
contribute to the clinical action of this 
drug. There has been very little work 
on the effect of ECT on MAO activity. 
The only human study, investigators could 
come across has been done by Mann 
(1979), who did not find any significant 
change in pretreatment and posttreat-
ment values. However, Pryor and Otis 
(1970) and Pryor ct al. (1972) working 
on animal brain MAO activity observed 
that multiple ECT causes increased 
enzyme activity persisting for several 
weeks. 
A significant decrease ir platelet 
MAO activity in post-treatment phase, 
as found in this investigation, supports 
the hypothesis of increased post synaptic 
activity of catecholamines after ECT 
(Grahame-Smith et al., 1978). There 
is still more research to go in establishing 
the exact mechanism of action of ECT. 
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